BioCryst Pharma (BCRX) Updates on BCX7353 Results in Japanese Volunteers; Plasma Drug Levels Seen Moderately Higher
Tweet Send to a Friend
BioCryst Pharma (NASDAQ: BCRX) disclosed the following on Friday:Item 7.01. Regulation FD Disclosure.BioCryst has previously reported results from a Phase ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
